AAQ1 aap Implantate AG

XETRA · DE · Healthcare · Medical Devices · aap.de

1.640EUR-5.75%Mkt Cap: 26.23M $P/E: —Today

aap Implantate AG develops, manufactures, and markets traumatology products for orthopedics in Germany and internationally. The company offers LOQTEQ, an anatomical plating system for the treatment of ankle, straight pla…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap26.23M USD

Enterprise Value31.32M USD

Revenue (TTM)13.27M USD

Gross Profit12.06M USD

Net Income (TTM)-2.81M USD

Revenue/Share0.87 EUR

Last Price1.640 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees105

CountryDE

SectorHealthcare

IndustryMedical Devices

ISINDE000A3H2101

Valuation

P/E (Trailing)—

P/E (Forward)-8.70

PEG29.43

EV/EBITDA-17.71

EV/Revenue2.36

P/S2.10

P/B3.07

EPS (TTM)-0.20

EPS (Forward)-0.20

52W Range

1.26040% of range2.220

52W High2.220 EUR

52W Low1.260 EUR

Profitability

Gross Margin88.87%

Oper. Margin-17.32%

EBITDA Margin-13.33%

Profit Margin-20.70%

ROE-29.73%

ROA-18.80%

Growth

Revenue Growth-4.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.56M USD

CapEx (TTM)788.04K USD

FCF Margin-3.82%

FCF Yield-1.93%

Net Debt4.01M USD

Net Debt/EBITDA-2.27

Balance Sheet

Debt/Equity0.11

Current Ratio2.07

Quick Ratio0.77

Book Value/Sh0.57 EUR

Cash/Share0.02 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateOct 29, 2020

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.14.72M

Float5.90M

Insiders61.81%

Institutions23.06%

Technical

SMA 501.618 (+1.4%)

SMA 2001.635 (+0.3%)

Beta0.33

S&P 52W Chg14.58%

Avg Vol (30d)1.56K

Avg Vol (10d)201

Technical Indicators

RSI (14)57.8

MACD0.0196

MACD Signal0.0243

MACD Hist.-0.0048

BB Upper1.787 EUR

BB Middle1.708 EUR

BB Lower1.630 EUR

BB Width9.19%

ATR (14)0.0879 EUR

Vol Ratio (20d)0.58x